Glide Pharmaceutical Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Out of Business

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Glide Pharmaceutical General Information

Description

Developer of a pharmaceutical development and device platform designed to offer needle-free injectors. The company's platform focuses on the needle-free administration of solid dose formulation of therapeutics and vaccines, that includes octreotide, teriparatide, exenatide and anthrax and influenza vaccines, enabling physicians improve treatment experiences of both patients and carers.

Contact Information

Formerly Known As
Caretek Medical
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Corporate Office
  • 45B/C Western Avenue
  • Milton Park, Oxfordshire
  • Abingdon OX14 4RU
  • England, United Kingdom
+44 01235 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glide Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Admin/Reorg 31-Aug-2017 Completed Bankruptcy: Admin/Reorg
9. Later Stage VC 01-Feb-2017 00.000 000.00 Completed Generating Revenue
8. Later Stage VC 12-Mar-2013 000.00 000.00 000.00 Completed Generating Revenue
7. Grant 05-Nov-2012 00.000 000.00 Completed Generating Revenue
6. Grant 01-Jun-2012 00000 000.00 Completed Generating Revenue
5. Later Stage VC 10-Feb-2010 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 23-Oct-2008 00.000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 13-Aug-2007 00.000 00.00 Completed Generating Revenue
2. Early Stage VC 06-Dec-2005 $3.63M $4.68M Completed Startup
1. Early Stage VC 24-Mar-2005 $1.05M $1.05M Completed Startup
To view Glide Pharmaceutical’s complete valuation and funding history, request access »

Glide Pharmaceutical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Ordinary 4 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 3 000,000 00.000000 00.0 00.0 00 00.0 0.000
Ordinary 2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 1 274,870 $0.000152 $7.63 $7.63 1x $7.63 2.8%
B Ordinary 42,956 $0.000152 $7.07 $7.07 1x $7.07 0.44%
To view Glide Pharmaceutical’s complete cap table history, request access »

Glide Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pharmaceutical development and device platform designed to offer needle-free injectors. The company's pla
Drug Delivery
Abingdon, United Kingdom
22 As of 2016
000.00
0000000000.

000 00

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
000000000000000
Goch, Germany
000 As of 0000
00000 0000-00-00
000000000000

000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
0000 00000000
Fremont, CA
00 As of 0000
00000
000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Glide Pharmaceutical Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DFE Pharma Private Equity-Backed Goch, Germany 000 000000000000
Zosano Pharma Formerly VC-backed Fremont, CA 00 00000 000000&0
Ability Pharma Private Equity-Backed Barcelona, Spain 00 000.00 0000000 0000 000.00
You’re viewing 3 of 3 competitors. Get the full list »

Glide Pharmaceutical Patents

Glide Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201518594-D0 Solid formation Inactive 20-Oct-2015 0000000000
GB-2545880-A Solid formulation Inactive 20-Oct-2015 0000000000 0
GB-201501697-D0 Injection device Inactive 02-Feb-2015 00000000000
JP-2021058682-A Injection device Active 02-Feb-2015 00000000000 0
GB-201101087-D0 Drug delivery technology Inactive 21-Jan-2011 A61M37/0069
To view Glide Pharmaceutical’s complete patent history, request access »

Glide Pharmaceutical Executive Team (10)

Name Title Board Seat Contact Info
Simon Jones Company Secretary
Genevieve Motte Ph.D Director, Development & Operations
You’re viewing 2 of 10 executive team members. Get the full list »

Glide Pharmaceutical Board Members (7)

Name Representing Role Since
Bryan Morton Self Chairman 000 0000
Richard Bungay Self Board Member 000 0000
You’re viewing 2 of 7 board members. Get the full list »

Glide Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glide Pharmaceutical FAQs

  • When was Glide Pharmaceutical founded?

    Glide Pharmaceutical was founded in 2001.

  • Who is the founder of Glide Pharmaceutical?

    Charles Potter Ph.D is the founder of Glide Pharmaceutical.

  • Where is Glide Pharmaceutical headquartered?

    Glide Pharmaceutical is headquartered in Abingdon, United Kingdom.

  • What is the size of Glide Pharmaceutical?

    Glide Pharmaceutical has 22 total employees.

  • What industry is Glide Pharmaceutical in?

    Glide Pharmaceutical’s primary industry is Drug Delivery.

  • Is Glide Pharmaceutical a private or public company?

    Glide Pharmaceutical is a Private company.

  • What is Glide Pharmaceutical’s current revenue?

    The current revenue for Glide Pharmaceutical is 000000.

  • How much funding has Glide Pharmaceutical raised over time?

    Glide Pharmaceutical has raised $43.1M.

  • Who are Glide Pharmaceutical’s competitors?

    DFE Pharma, Zosano Pharma, and Ability Pharma are competitors of Glide Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »